Carlton Donald
Affiliations: | Medical University of South Carolina, Charleston, SC, United States |
Area:
Molecular BiologyGoogle:
"Carlton Donald"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Bose SK, Gibson W, Giri S, et al. (2009) Angiotensin II up-regulates PAX2 oncogene expression and activity in prostate cancer via the angiotensin II type I receptor. The Prostate. 69: 1334-42 |
| Bose SK, Gibson W, Bullard RS, et al. (2009) PAX2 oncogene negatively regulates the expression of the host defense peptide human beta defensin-1 in prostate cancer. Molecular Immunology. 46: 1140-8 |
| Bose SK, Bullard RS, Donald CD. (2008) Oncogenic role of engrailed-2 (en-2) in prostate cancer cell growth and survival. Translational Oncogenomics. 3: 37-43 |
| Cooper CR, Graves B, Pruitt F, et al. (2008) Novel surface expression of reticulocalbin 1 on bone endothelial cells and human prostate cancer cells is regulated by TNF-alpha. Journal of Cellular Biochemistry. 104: 2298-309 |
| Bullard RS, Gibson W, Bose SK, et al. (2008) Functional analysis of the host defense peptide Human Beta Defensin-1: new insight into its potential role in cancer. Molecular Immunology. 45: 839-48 |
| Gibson W, Green A, Bullard RS, et al. (2007) Inhibition of PAX2 expression results in alternate cell death pathways in prostate cancer cells differing in p53 status. Cancer Letters. 248: 251-61 |
| Chen WW, Chan DC, Donald C, et al. (2005) Pim family kinases enhance tumor growth of prostate cancer cells. Molecular Cancer Research : McR. 3: 443-51 |
| Donald CD, Sun CQ, Lim SD, et al. (2003) Cancer-specific loss of beta-defensin 1 in renal and prostatic carcinomas. Laboratory Investigation; a Journal of Technical Methods and Pathology. 83: 501-5 |